35510084|t|Galantamine tethered hydrogel as a novel therapeutic target for streptozotocin-induced Alzheimer's disease in Wistar rats.
35510084|a|Amyloid-beta (Abeta) plaque formation, neuronal cell death, and cognitive impairment are the unique symptoms of Alzheimer's disease (AD). No single step remedy is available to treat AD, so the present study aimed to improve the drugability and minimize the abnormal behavioral and biochemical activities in streptozotocin (STZ) induced AD experimental Wistar rats. In particular, we explored the utilization of methacrylated gelatin (GelMA), which is a biopolymeric hydrogel that mimics the natural tissue environment. The synthesized biopolymeric gel contained the drug galantamine (Gal). Investigations were conducted to evaluate the behavioral activities of STZ-induced AD experimental rats under STZ + GelMA + Gal treatment. The experimental groups comprised the control and STZ, STZ + GelMA, STZ + Gal, and STZ + GelMA + Gal (10 mg/kg) treated rats. Intracerebroventricular STZ ensures cognitive decline in terms of an increase in the escape latency period, with a decrease in the spontaneous alteration of behavioral activities. Our results indicated decrease Abeta aggregation in the hydrogel-based drug treatment group and significant decreases in the levels of acetylcholinesterase and lipid peroxidation (p < 0.001). In addition, the glutathione and superoxide dismutase activities appeared to be improved in the STZ + GelMA + Gal group compared with the other treatment groups. Furthermore, histopathological and immunohistochemical experiments showed that the GelMA + Gal treated AD rats exhibited significantly improved behavioral and biochemical activities compared with the STZ treated AD rats. Therefore, STZ + GelMA + Gal administration from the pre-plaque stage may have a potential clinical application in the prevention of AD. Thus, we conclude that hydrogel-based Gal drugs are efficient at decreasing Abeta aggregation and improving the neuroinflammatory process, antioxidant activity, and neuronal growth.
35510084	0	11	Galantamine	Chemical	MESH:D005702
35510084	64	78	streptozotocin	Chemical	MESH:D013311
35510084	87	106	Alzheimer's disease	Disease	MESH:D000544
35510084	117	121	rats	Species	10116
35510084	137	142	Abeta	Gene	54226
35510084	187	207	cognitive impairment	Disease	MESH:D003072
35510084	235	254	Alzheimer's disease	Disease	MESH:D000544
35510084	256	258	AD	Disease	MESH:D000544
35510084	305	307	AD	Disease	MESH:D000544
35510084	430	444	streptozotocin	Chemical	MESH:D013311
35510084	446	449	STZ	Chemical	MESH:D013311
35510084	459	461	AD	Disease	MESH:D000544
35510084	482	486	rats	Species	10116
35510084	534	555	methacrylated gelatin	Chemical	-
35510084	557	562	GelMA	Chemical	-
35510084	694	705	galantamine	Chemical	MESH:D005702
35510084	707	710	Gal	Chemical	MESH:D005702
35510084	784	787	STZ	Chemical	MESH:D013311
35510084	796	798	AD	Disease	MESH:D000544
35510084	812	816	rats	Species	10116
35510084	823	826	STZ	Chemical	MESH:D013311
35510084	829	834	GelMA	Chemical	-
35510084	837	840	Gal	Chemical	MESH:D005702
35510084	902	905	STZ	Chemical	MESH:D013311
35510084	907	910	STZ	Chemical	MESH:D013311
35510084	913	918	GelMA	Chemical	-
35510084	920	923	STZ	Chemical	MESH:D013311
35510084	926	929	Gal	Chemical	MESH:D005702
35510084	935	938	STZ	Chemical	MESH:D013311
35510084	941	946	GelMA	Chemical	-
35510084	949	952	Gal	Chemical	MESH:D005702
35510084	972	976	rats	Species	10116
35510084	1002	1005	STZ	Chemical	MESH:D013311
35510084	1014	1031	cognitive decline	Disease	MESH:D003072
35510084	1189	1194	Abeta	Gene	54226
35510084	1293	1313	acetylcholinesterase	Gene	83817
35510084	1318	1323	lipid	Chemical	MESH:D008055
35510084	1367	1378	glutathione	Chemical	MESH:D005978
35510084	1446	1449	STZ	Chemical	MESH:D013311
35510084	1452	1457	GelMA	Chemical	-
35510084	1460	1463	Gal	Chemical	MESH:D005702
35510084	1595	1600	GelMA	Chemical	-
35510084	1603	1606	Gal	Chemical	MESH:D005702
35510084	1615	1617	AD	Disease	MESH:D000544
35510084	1618	1622	rats	Species	10116
35510084	1712	1715	STZ	Chemical	MESH:D013311
35510084	1724	1726	AD	Disease	MESH:D000544
35510084	1727	1731	rats	Species	10116
35510084	1744	1747	STZ	Chemical	MESH:D013311
35510084	1750	1755	GelMA	Chemical	-
35510084	1758	1761	Gal	Chemical	MESH:D005702
35510084	1866	1868	AD	Disease	MESH:D000544
35510084	1908	1911	Gal	Chemical	MESH:D005702
35510084	1946	1951	Abeta	Gene	54226
35510084	1982	1999	neuroinflammatory	Disease	MESH:D000090862
35510084	Negative_Correlation	MESH:D005702	83817
35510084	Positive_Correlation	MESH:D013311	MESH:D003072
35510084	Negative_Correlation	MESH:D005702	MESH:D013311
35510084	Association	MESH:D000544	54226
35510084	Positive_Correlation	MESH:D005702	MESH:D000090862
35510084	Positive_Correlation	MESH:D013311	MESH:D000544
35510084	Negative_Correlation	MESH:D005702	54226
35510084	Negative_Correlation	MESH:D005702	MESH:D000544
35510084	Positive_Correlation	MESH:D005978	MESH:D013311
35510084	Positive_Correlation	MESH:D005702	MESH:D005978

